Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn how pathological diagnosis and biomarker testing guide targeted therapy selection for breast cancer patients in this 47-minute webinar. Explore the critical role pathologists play in determining appropriate treatment options by examining estrogen receptor, progesterone receptor, and HER2 biomarkers that are essential for therapy selection. Discover how proper pathologic diagnosis serves as the foundation for identifying which breast cancer patients require additional tumor testing and which targeted therapies will provide the best survival outcomes. Gain insights into the evolution of breast cancer treatment options over the past 25 years and understand how advances in pathological testing have contributed to improved patient survival rates. Examine the relationship between accurate biomarker assessment and personalized treatment approaches for the most common cancer diagnosed in women and second leading cause of female cancer death in the United States.
